share_log

RBC Capital Reiterates Sector Perform on Spruce Biosciences, Maintains $2 Price Target

Benzinga ·  Aug 14 00:29  · Ratings

RBC Capital analyst Gregory Renza reiterates Spruce Biosciences (NASDAQ:SPRB) with a Sector Perform and maintains $2 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment